Related Experiment Video
Updated: May 8, 2026
10:16
Hypoxic Preconditioning of Marrow-derived Progenitor Cells As a Source for the Generation of Mature Schwann Cells
Published on: June 14, 2017
Undifferentiated MSCs are able to myelinate DRG neuron processes through p75
Maddalena Ravasi1, Arianna Scuteri, Silvia Pasini
1Dipartimento di Chirurgia e Medicina Interdisciplinare, Università degli Studi di Milano-Bicocca, via Cadore 48, 20900 Monza, Italy.
Experimental Cell Research
|August 27, 2013
Summary
Undifferentiated Mesenchymal Stem Cells (MSCs) can myelinate nerve cell processes, offering a promising regenerative approach for demyelinating diseases. This study highlights the p75 receptor
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Biology
Background:
- Demyelinating diseases require new therapeutic strategies beyond symptomatic treatment.
- Mesenchymal Stem Cells (MSCs) are a versatile cell source for regenerative medicine.
- While glially-primed MSCs show myelination potential, undifferentiated MSC capabilities are less understood.
Purpose of the Study:
- To investigate the myelination potential of undifferentiated Mesenchymal Stem Cells (MSCs).
- To explore the role of the p75 receptor in MSC-mediated myelination.
Main Methods:
- Co-culturing of undifferentiated rat Mesenchymal Stem Cells (MSCs) with dorsal root ganglion (DRG) neurons.
- Assessment of myelination induction by undifferentiated MSCs.
- Analysis of the p75 receptor's involvement in the process.
Main Results:
- Undifferentiated Mesenchymal Stem Cells (MSCs) successfully induced myelination of rat DRG neuron processes.
- Direct co-culturing was sufficient to promote myelination.
- The p75 receptor plays a crucial role in this myelination process.
Conclusions:
- Undifferentiated Mesenchymal Stem Cells (MSCs) possess intrinsic myelination capabilities.
- MSC-based therapies offer a potential regenerative strategy for demyelinating conditions.
- Targeting the p75 receptor could enhance MSC-mediated remyelination therapies.
